India's industry issues response to government's new clinical trial guidelines
This article was originally published in Clinica
Executive Summary
One month ahead of India's release of new ethical guidelines for clinical trials, including for stem cell research, tissue engineering, and molecular diagnostics, the Federation of Indian Chambers of Commerce and Industry (FICCI) has brought out its own white paper.